Ann: Director and management update, page-34

uncertainty yes but I think there was far more uncertainty when they announced the Apirx acquisition and then went radio silent lol. Now that the commercial and drug development strategy is pretty clear I think it will be fine. IHL will join the rest of the sector in its eventual and probably overdue recovery when it happens